Evidence map›Paper›PMID 19026659›Full record

ArticleJournal of molecular biology2009

In silico vaccine design based on molecular simulations of rhinovirus chimeras presenting HIV-1 gp41 epitopes.

Mauro Lapelosa, Emilio Gallicchio, Gail Ferstandig Arnold, Eddy Arnold, Ronald M Levy

Abstract read
In one paragraph

Article in Journal of molecular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Computer-aided antibody design.Protein engineering, design & selection : PEDS · 2012
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mauro LapelosaBioMaPS Institute for Quantitative Biology, Rutgers University, Piscataway, NJ 08854, USA.
Emilio Gallicchio
Gail Ferstandig Arnold
Eddy Arnold
Ronald M Levy

Funding

DYNAMICS OF PEPTIDES AND PROTEINSR01GM030580 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI LEVY, RONALD · 1985 to 2018
$6.1M
Broad Neutralization of HIV-1 from Rhinoviruses Displaying gp41 MPER SequencesR01AI071874 · NIAID · RUTGERS, THE STATE UNIV OF N.J. · PI ARNOLD, GAIL F · 2006 to 2009
$1.7M
Computer Cluster for Computational and Structural BiologyS10RR022375 · NCRR · RUTGERS, THE STATE UNIV OF N.J. · PI LEVY, RONALD · 2007 to 2007
$291k
NCRR NIH HHS 1 S10 RR022375NCRR NIH HHS S10 RR022375NIAID NIH HHS 1AI071874NIAID NIH HHS R01 AI071874NIGMS NIH HHS GM30580NIGMS NIH HHS R01 GM030580
6 · The paper itself

Abstract

A cluster of promising epitopes for the development of human immunodeficiency virus (HIV) vaccines is located in the membrane-proximal external region (MPER) of the gp41 subunit of the HIV envelope spike structure. The crystal structure of the peptide corresponding to the so-called ELDKWA epitope (HIV-1 HxB2 gp41 residues 662-668), in complex with the corresponding broadly neutralizing human monoclonal antibody 2F5, provides a target for structure-based vaccine design strategies aimed at finding macromolecular carriers that are able to present this MPER-derived epitope with optimal antigenic activity. To this end, a series of replica exchange molecular dynamics computer simulations was conducted to characterize the distributions of conformations of ELDKWA-based epitopes inserted into a rhinovirus carrier and to identify those with the highest fraction of conformations that are able to bind 2F5. The length, hydrophobic character, and precise site of insertion were found to be critical for achieving structural similarity to the target crystal structure. A construct with a high degree of complementarity to the corresponding determinant region of 2F5 was obtained. This construct was employed to build a high-resolution structural model of the complex between the 2F5 antibody and the chimeric human rhinovirus type 14:HIV-1 ELDKWA virus particle. Additional simulations, which were conducted to study the conformational propensities of the ELDKWA region in solution, confirm the hypothesis that the ELDKWA region of gp41 is highly flexible and capable of assuming helical conformations (as in the postfusion helical bundle structure) and beta-turn conformations (as in the complex with the 2F5 antibody). These results also suggest that the ELDKWA epitope can be involved in intramolecular--and likely intermolecular--hydrophobic interactions. This tendency offers an explanation for the observation that mutations decreasing the hydrophobic character of the MPER in many cases result in conformational changes that increase the affinity of this region for the 2F5 antibody.

Indexed as

Drug DesignAIDS VaccinesAntibodies, MonoclonalEpitopesHIV AntibodiesHIV Envelope Protein gp41HumansModels, MolecularProtein ConformationProtein Structure, TertiaryRhinovirusAIDS VaccinesAntibodies, MonoclonalEpitopesgp41 protein, Human immunodeficiency virus 1HIV AntibodiesHIV Envelope Protein gp41

Identifiers

PMID19026659
PMCPMC2649764

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.